A Study of LY4515100 in Participants With Pain Following Third Molar Removal

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to evaluate the safety and efficacy of LY4515100 and see how a single oral dose compares with placebo in acute postsurgical pain after removing impacted third molars. For each participant, the study may last approximately 6 weeks and will include a stay in a Clinical Research Unit (CRU) after third molar removal.
Epistemonikos ID: 16cedcc0534db795fff8c885feac6046003112e4
First added on: Apr 07, 2026